Pfizer, Inc. (PFE) is currently trading at $25.85. Based on 27 Wall Street analysts, the average target price is $29.19, implying a 12.9% upside. The consensus recommendation is BUY.

PFE

Pfizer, Inc.

HealthcareOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$25.85

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

LowHigh
$25.00$36.00
Current $25.85
Median: $28.00Mean: $29.89Current: $25.85

Recent price target updates (latest 80)

  • CitigroupApr 29, 2026

    PT action: Raises

    $26.00 → $27.00

  • RBC CapitalApr 20, 2026

    PT action: Maintains

    $25.00 → $25.00

  • CICCApr 16, 2026

    PT action: Announces

    $0.00 → $33.00

  • UBSApr 13, 2026

    PT action: Raises

    $25.00 → $27.00

  • Morgan StanleyApr 10, 2026

    PT action: Raises

    $27.00 → $28.00

  • B of A SecuritiesApr 9, 2026

    PT action: Lowers

    $27.00 → $26.00

  • GuggenheimMar 24, 2026

    PT action: Raises

    $35.00 → $36.00

  • HSBCMar 17, 2026

    PT action: Raises

    $29.00 → $32.00

  • Argus ResearchMar 2, 2026

    PT action: Announces

    $0.00 → $35.00

  • RBC CapitalFeb 25, 2026

    PT action: Announces

    $0.00 → $25.00

  • BarclaysFeb 20, 2026

    PT action: Announces

    $0.00 → $25.00

  • Freedom BrokerFeb 9, 2026

    PT action: Lowers

    $35.00 → $33.00

  • Cantor FitzgeraldFeb 4, 2026

    PT action: Maintains

    $27.00 → $27.00

  • Cantor FitzgeraldJan 27, 2026

    PT action: Raises

    $24.00 → $27.00

  • Morgan StanleyDec 17, 2025

    PT action: Lowers

    $28.00 → $27.00

  • B of A SecuritiesDec 15, 2025

    PT action: Lowers

    $29.00 → $28.00

  • Morgan StanleyDec 12, 2025

    PT action: Lowers

    $32.00 → $28.00

  • GuggenheimNov 24, 2025

    PT action: Raises

    $33.00 → $35.00

  • Morgan StanleyOct 10, 2025

    PT action: Lowers

    $33.00 → $32.00

  • B of A SecuritiesOct 3, 2025

    PT action: Raises

    $28.00 → $30.00

  • CitigroupAug 6, 2025

    PT action: Raises

    $25.00 → $26.00

  • Morgan StanleyAug 6, 2025

    PT action: Raises

    $32.00 → $33.00

  • B of A SecuritiesAug 6, 2025

    PT action: Raises

    $27.00 → $28.00

  • UBSApr 30, 2025

    PT action: Raises

    $24.00 → $25.00

  • Cantor FitzgeraldApr 22, 2025

    PT action: Announces

    $0.00 → $24.00

  • UBSApr 8, 2025

    PT action: Lowers

    $28.00 → $24.00

  • Goldman SachsApr 8, 2025

    PT action: Lowers

    $32.00 → $25.00

  • GuggenheimMar 18, 2025

    PT action:

    $0.00 → $0.00

  • GuggenheimMar 12, 2025

    PT action:

    $0.00 → $0.00

  • GuggenheimFeb 10, 2025

    PT action: Maintains

    $33.00 → $33.00

  • UBSFeb 5, 2025

    PT action: Lowers

    $29.00 → $28.00

  • CitigroupJan 28, 2025

    PT action: Lowers

    $30.00 → $29.00

  • UBSJan 8, 2025

    PT action: Lowers

    $31.00 → $29.00

  • Truist SecuritiesDec 18, 2024

    PT action: Lowers

    $36.00 → $32.00

  • GuggenheimDec 11, 2024

    PT action: Lowers

    $35.00 → $33.00

  • Wolfe ResearchNov 15, 2024

    PT action: Announces

    $0.00 → $25.00

  • Morgan StanleyOct 30, 2024

    PT action: Raises

    $30.00 → $31.00

  • Cantor FitzgeraldOct 25, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldOct 23, 2024

    PT action: Maintains

    $45.00 → $45.00

  • BernsteinOct 17, 2024

    PT action: Announces

    $0.00 → $32.00

  • Morgan StanleyOct 11, 2024

    PT action: Lowers

    $31.00 → $30.00

  • Cantor FitzgeraldOct 3, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldSep 16, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldSep 9, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldAug 19, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Daiwa CapitalAug 8, 2024

    PT action: Raises

    $28.00 → $34.00

  • BarclaysJul 31, 2024

    PT action: Raises

    $30.00 → $32.00

  • Wells FargoJul 31, 2024

    PT action: Raises

    $28.00 → $30.00

  • Cantor FitzgeraldJul 31, 2024

    PT action: Maintains

    $45.00 → $45.00

  • UBSJul 31, 2024

    PT action: Raises

    $30.00 → $31.00

  • BarclaysJul 10, 2024

    PT action: Raises

    $28.00 → $30.00

  • Cantor FitzgeraldJul 10, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldJul 1, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldJun 26, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldJun 20, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldJun 17, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Morgan StanleyMay 2, 2024

    PT action: Raises

    $28.00 → $29.00

  • BMO CapitalMay 2, 2024

    PT action: Raises

    $33.00 → $36.00

  • Cantor FitzgeraldApr 18, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldApr 15, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldApr 5, 2024

    PT action: Maintains

    $45.00 → $45.00

  • Cantor FitzgeraldApr 1, 2024

    PT action: Maintains

    $0.00 → $45.00

  • Argus ResearchMar 22, 2024

    PT action:

    $0.00 → $0.00

  • Cantor FitzgeraldMar 4, 2024

    PT action: Maintains

    $0.00 → $45.00

  • Cantor FitzgeraldMar 1, 2024

    PT action: Maintains

    $0.00 → $45.00

  • GuggenheimFeb 23, 2024

    PT action: Announces

    $0.00 → $36.00

  • Cantor FitzgeraldJan 31, 2024

    PT action: Maintains

    $0.00 → $45.00

  • Cantor FitzgeraldJan 9, 2024

    PT action: Maintains

    $0.00 → $45.00

  • TD CowenJan 4, 2024

    PT action: Announces

    $0.00 → $32.00

  • Truist SecuritiesDec 14, 2023

    PT action: Lowers

    $42.00 → $36.00

  • UBSDec 14, 2023

    PT action: Lowers

    $34.00 → $27.00

  • BarclaysDec 14, 2023

    PT action: Lowers

    $34.00 → $28.00

  • Truist SecuritiesDec 4, 2023

    PT action: Maintains

    $0.00 → $42.00

  • Cantor FitzgeraldNov 20, 2023

    PT action: Maintains

    $0.00 → $75.00

  • BarclaysNov 1, 2023

    PT action: Lowers

    $35.00 → $34.00

  • Morgan StanleyNov 1, 2023

    PT action: Lowers

    $39.00 → $37.00

  • Truist SecuritiesOct 17, 2023

    PT action: Lowers

    $62.00 → $42.00

  • Morgan StanleyOct 17, 2023

    PT action: Lowers

    $40.00 → $39.00

  • Wells FargoOct 17, 2023

    PT action: Lowers

    $39.00 → $35.00

  • BMO CapitalOct 16, 2023

    PT action: Lowers

    $44.00 → $33.00

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$29.19

Based on 27 analysts

Analyst Recommendations

Buy (11)Hold (15)Sell (3)

Upside

+12.91%

Market Cap

$147.33B

Financial & Investment Metrics

Next Earnings Date
Jul 29, 2026D-63
P/E Ratio (TTM)19.73
Forward P/E9.11
P/B Ratio1.70
Dividend Yield6.64%
Return on Equity (ROE)8.31%
Operating Margin31.62%
Debt to Equity71.60
Beta (Volatility)0.30
52 Week Range$23.06 - $28.75
LowCurrent: $25.85High

Latest News

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 2Insider Sells: 2

Whale Trades (C-Level Large Buys)

Major insider buying detected recently.

BLAYLOCK RONALD E (Director) - 19,457 shares

Recent Insider Transactions

DateNamePositionTransactionShares
3/4/2025DAMICO JENNIFER B.OfficerSale at price 25.93 per share.2,500
2/13/2025BLAYLOCK RONALD EDirectorPurchase at price 25.65 per share.19,457
10/30/2024GOTTLIEB SCOTTDirectorPurchase at price 28.24 per share.1,000
8/13/2024DAMICO JENNIFER B.OfficerSale at price 28.66 per share.5,154

Frequently Asked Questions

Q. What is the current target price and upside for PFE?

A. The current target price for Pfizer, Inc. is $29.19, which implies a 12.9% upside from the current price of $25.85. This is based on the consensus of 27 Wall Street analysts.

Q. What is the current analyst recommendation for PFE?

A. Currently, there are 2 Strong Buy, 9 Buy, 15 Hold, 1 Sell, and 2 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying PFE stock recently?

A. Over the past 6 months, there have been 2 insider buys and 2 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Healthcare

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer
No login requiredNo personal data collectedData source: Yahoo Finance (public)For informational purposes only — not financial advice
PFE (Pfizer, Inc.) Stock Analysis | Analyst Signal